What’s In Store For Merck Stock In 2025?
Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.
What are the symptoms of emphysema?
Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...